Fiera Capital (Canada)’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-1,760
Closed -$237K 670
2018
Q3
$237K Buy
+1,760
New +$217K ﹤0.01% 646
2018
Q2
Sell
-83,901
Closed -$8.96M 696
2018
Q1
$8.96M Sell
83,901
-11,431
-12% -$1.23M 0.04% 221
2017
Q4
$10.4M Sell
95,332
-18,991
-17% -$2.07M 0.05% 219
2017
Q3
$12.3M Sell
114,323
-7,660
-6% -$787K 0.06% 221
2017
Q2
$12.3M Sell
121,983
-17,470
-13% -$1.61M 0.06% 214
2017
Q1
$12.5M Sell
139,453
-7,327
-5% -$622K 0.07% 210
2016
Q4
$11.2M Sell
146,780
-21,697
-13% -$1.65M 0.06% 225
2016
Q3
$14M Sell
168,477
-6,484
-4% -$544K 0.08% 204
2016
Q2
$14.4M Buy
+174,961
New +$14.4M 0.08% 208

Other funds holding CRL

Fiera Capital (Canada)'s CRL Position: Q4 2018 in Review

Fiera Capital (Canada) sold out of Charles River Laboratories (CRL) in Q4 2018, closing a stake of 1,760 shares — an estimated $237K sold.

Fiera Capital (Canada) first reported a position in CRL in Q2 2016 and held it in 9 quarters. The position peaked at $14.4M in Q2 2016. 407 funds tracked by Wall St. Rank hold CRL as of Q4 2018.

  • Fiera Capital (Canada) reported no remaining Charles River Laboratories position as of Q4 2018 after selling out during the quarter.
  • Fiera Capital (Canada) sold 1,760 Charles River Laboratories shares in Q4 2018, an estimated $237K.
  • Fiera Capital (Canada) first reported a position in Charles River Laboratories in Q2 2016 and held it in 9 quarters.
  • Fiera Capital (Canada)'s Charles River Laboratories position peaked at $14.4M in Q2 2016.
  • 407 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2018.

Based on Fiera Capital (Canada)'s 13F filing for Q4 2018, filed 12 Feb 2019.